Novartis Investigative Site

Redhill, Surrey RH1 5RH

0 studies enrolling now · 3 studies all time

What they study most

Chronic Heart Failure With Reduced Ejection Fraction, Chronic Plaque Type Psoriasis, Heart Failure With Reduced Ejection Fraction

Studies at this site

• Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction — Completed
• Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early